High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback

  • Lu D
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

AIDS (acquired immune deficient syndrome) is a human infectious disease. AIDS patients, if not be treated, commonly suffer a gradual loss of human immune-defensive functions and finally die of infectious complications within 2 years after AIDS symptoms occur in patients. AIDS patients can be treated with a series of anti-viral drugs to decrease the virus-load and slow the pace of occurrence AIDS and ameliorate the symptoms of immune deficient and prolong the life-spans of patients by high active anti-retroviral therapy (HAART). Even though HAART is very effective, HIV/AIDS patients cannot be cured by HAART. And there are a lot of precautious for this therapy. There are a plethora of reasons behind these phenomena. In this review, we will detail address this problem and try to give new directions

Cite

CITATION STYLE

APA

Lu, D.-Y. (2012). High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback. Advances in Pharmacoepidemiology & Drug Safety, 01(06). https://doi.org/10.4172/2167-1052.1000e115

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free